These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 8144120

  • 21. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD, Fisher L, Elta GH, Barnett JL, Nostrant T, DelValle J, Hasler WL, Scheiman JM.
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [Abstract] [Full Text] [Related]

  • 22. Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study.
    Gupta VK, Dhar A, Srinivasan S, Rattan A, Sharma MP.
    Am J Gastroenterol; 1997 Jul; 92(7):1140-2. PubMed ID: 9219786
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Proton-pump inhibitor-refractory gastric ulcer and Helicobacter pylori.
    Arakawa T, Kimura S, Uchida T, Higuchi K, Fukuda T, Kobayashi K.
    Am J Gastroenterol; 1993 Aug; 88(8):1295. PubMed ID: 8338112
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Helicobacter pylori infection.
    Delaney B, Moayyedi P, Forman D.
    Clin Evid; 2002 Dec; (8):453-68. PubMed ID: 12603894
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
    Lazzaroni M, Bargiggia S, Bianchi Porro G.
    Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
    [Abstract] [Full Text] [Related]

  • 31. Proton-pump inhibitors in acid-related diseases.
    Berardi RR, Welage LS.
    Am J Health Syst Pharm; 1998 Nov 01; 55(21):2289-98. PubMed ID: 9825880
    [No Abstract] [Full Text] [Related]

  • 32. [2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
    Leonhardt U, Ritzel U, Ramadori G.
    Internist (Berl); 1996 Sep 01; 37(9):944-9; discussion 949. PubMed ID: 8964694
    [No Abstract] [Full Text] [Related]

  • 33. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A, Celikel CA, Ozdogan O, Tözün N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2005 Dec 01; 20(12):1886-91. PubMed ID: 16336449
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004 Dec 01; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 36. Proceedings of the 2nd International Colloquium on Proton Pump Inhibitors.
    J Clin Gastroenterol; 1995 Dec 01; 20 Suppl 1():S1-51. PubMed ID: 7673606
    [No Abstract] [Full Text] [Related]

  • 37. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.
    Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P.
    Gut; 1997 Dec 01; 41(6):740-7. PubMed ID: 9462205
    [Abstract] [Full Text] [Related]

  • 38. [Short-term intervention in ulcer and reflux. New acid blocker halves duration of therapy].
    Einecke D.
    MMW Fortschr Med; 2000 Jul 06; 142(26-27):50-1. PubMed ID: 10929487
    [No Abstract] [Full Text] [Related]

  • 39. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU, Granström M, Hoang TT, Phuncarg DC, Nilsson LE, Sörberg M.
    Aliment Pharmacol Ther; 2004 Jun 15; 19(12):1315-21. PubMed ID: 15191514
    [Abstract] [Full Text] [Related]

  • 40. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
    Mak SK, Loo CK, Wong PN, Lo KY, Tong GM, Lam EK, Wong AK.
    Singapore Med J; 2003 Feb 15; 44(2):74-8. PubMed ID: 14503780
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.